Pay in 4 interest-free payments of $5.01 Learn more
Ships within 48 hours · Estimated delivery Aug 28 - Sep 2
Clinical evidence from the SURMOUNT trials demonstrated that tirzepatide produces weight losses ranging from 21% to 22.5% of baseline body weight at the highest maintenance dose, representing outcomes significantly greater than older GLP-1 monotherapy agents
Don't take a large dose of this medicine, as it may be dangerous to your body
Weeks 3 to 8 (1.8 to 3.0 mg): As the dose reaches maintenance levels, appetite reduction becomes more consistent
This page is here to help with that exact moment
US$ 29.32
US$ 27.30
US$ 21.22
US$ 23.65
US$ 22.01
US$ 22.58
US$ 23.56
